San Diego biotech Evofem Biosciences, which focuses on women’s sexual and reproductive health, announced a public stock offering on May 22.
BIOTECH: From Cancer to Concussions, Efforts Change Cost, Course of Treatments
Banyan Biomarkers hit a milestone in February when its blood test for traumatic brain injuries won U.S. Food and Drug Administration approval.
San Diego’s AristaMD has hired Adam Darkins, known for his work with the Department of Veterans Affairs, as the company's chief strategy officer.
The Gary and Mary West Emergency Department at UC San Diego Health last week was accredited as a geriatric emergency department, the first such accreditation in California and one of only eight nationally.
San Diego-based Cidara Therapeutics and Rutgers University were awarded a $5.5 million grant to research and further develop an immunotherapy platform.
HEALTH: Drug Treats Seizures; Co. Prepares For Commercialization
A plant-derived cannabis medicine is poised to be the first of its kind to win U.S. Food and Drug Administration approval. A winner of the expected greenlight: Carlsbad’s Greenwich Biosciences.
PHARMA: Co. Transforms After Weight-Loss Flop
Arena Pharmaceuticals’ weight-loss drug flopped a few years ago, signaling a bleak future. That is, if you ignored Arena’s shelved compounds.
Accelerator Life Science Partners, a life science investment and management firm, has opened a San Diego office at The Alexandria at Torrey Pines.
Former film executive Sherry Lansing, who led Paramount and Fox motion picture studios, has been named to The Scripps Research Institute board.
BIOTECH: Acquisition Moves Co. Toward Push-Button Process for Analysis
Illumina bought data processing specialist Edico Genome for $100 million as part of a bid to expand genomics testing in research and health care.
Genomics giant Illumina has purchased Edico Genome, adding a processing platform to Illumina’s portfolio.
San Diego-based MEI Pharma reported on May 14 raising $75 million through a private placement, led by Vivo Capital and CAM Capital.
San Diego biotech Cidara Therapeutics reported a net loss of $16.7 million in the first quarter, compared to a $13.14 million net loss in the first quarter of last year.
PHARMA: Partnerships and Promising Pipeline Boost Co.
When Stanley Crooke formed Ionis Pharmaceuticals in 1989, he saw the venture as a longshot. He told investors as much.
San Diego-based Escient Pharmaceuticals launched with a $40 million Series A round, which will go toward a pipeline of novel drugs.
San Diego-based Neurana Pharmaceuticals raised $60 million in Series A financing for a relaxant that treats acute, painful muscle spasms.
Solana Beach-based Luna DNA raised $2 million in a new round of funding, led by Illumina Ventures and Arch Venture Partners, it was announced May 8.
FINANCE: Q1 Delivers Record Investment Locally and Nationally
Investment in San Diego-based life sciences companies hit a record high $417.9 million in quarter one of 2018, according to an April CBRE Group Inc. report.
The Scripps Translational Science Institute (STSI) was awarded $34 million in renewed funding to advance genomic and digital technologies in clinical care.
AMN Healthcare reported $522 million in quarter one revenue, up 6 percent year over year, fueled by higher-than-expected staffing needs.
TRADE: S.D. Cos. Able to Avoid Some of the Complexities
San Diego biotechs are inking deals with Chinese firms to tap into China’s ever-growing demand for groundbreaking drugs.
San Diego-based Dexcom reported a 30 percent year-over-year revenue increase in quarter one results due a sharp increase in international sales.
NuVasive reported $260.5 million in quarter one results, a 4.6 percent year-over year increase, with its core U.S. hardware business showing solid growth.
San Diego-based Synthorx — formed around synthetic biology for novel protein therapies — raised $63 million in a Series C round.
San Diego-based ResMed reported $591.6 million in third quarter revenue, a 15 percent year-over-year increase.
HEALTH: Revenue Needs, Market Trends Push Change
San Diego hospitals in the last few years boosted investment in modest freestanding centers for surgery, imaging and other services, vying for patients seeking convenience and lower costs.
The U.S. Food and Drug Administration said it was reexamining San Diego-based Acadia Pharmaceuticals’ drug to treat hallucinations and delusions caused by Parkinson’s disease. The news was first reported by CNN on April 25.
Illumina reported $782 million in first quarter revenue, a 31 percent year-over-year increase, the company announced April 24.
Steve Martin, a seasoned CFO, has joined Dthera Sciences’ board.
UC San Diego’s Skaggs School of Pharmacy and Pharmaceutical Sciences has launched a master of science in drug development and product management, a first-of-its-kind offering.
BIotECH: Model for NASH Drug Testing,Tissue for Bridge Solutions Are Goals
Organovo’s technology sounds straight out of science fiction movies: 3-D printed tissues that emulate human organs. But, this story is shifting.
Biogen will pay Carlsbad’s Ionis Pharmaceuticals $1 billion in cash as part of a 10-year collaboration around neurological drug development.
BIOTECH: Software Success To Move On to Analytics, AI
Five years ago, Michael “Mick” Farrell listened to an analyst forecast ResMed’s demise.
Citing regulatory changes, San Diego’s Tocagen licensed its immunotherapy for commercialization in China, earning the company $16 million upfront and potentially much more.
French diagnostics giant bioMérieux acquired San Diego-based Astute Medical in a $90 million cash deal announced earlier this month.
Sharp Grossmont Hospital has opened a new clinic, which looks to reduce patient volumes in the hospital’s emergency room, one of the busiest in San Diego County.
Biological Dynamics, a San Diego cancer diagnostics company, named Irwin Jacobs and Martin Wygod to its board, it was announced April 13.
Tandem Diabetes Care reported a 42 percent year-over-year increase in preliminary quarter one sales, increasing the company’s stock.
BIOTECH: Partnership, Sales Boost Are Part of Positives
Tandem Diabetes Care believes the storm has passed.
BIOTECH: Optum360’s System Covers All the Bases for Variety of Users
A San Diego offshoot is deploying artificial intelligence against a crushing administrative burden: electronic health records.
San Diego-based ResMed has hired Bobby Ghoshal as the company’s first chief technology officer.
After 22 years as Sharp Healthcare’s CEO, Michael Murphy plans to retire February 2019.
LEGAL: Avoiding It Can Be Tricky for Law Firms
A Carlsbad spine surgery company recently sued a law firm, highlighting a thicket of conflict-of-interest issues lawyers wade through in choosing clients.
Arcturus Therapeutics is suing its former CEO, nearly two months after he challenged the legality of the company terminating him.
La Jolla-based Singlera Genomics has raised $60 million in a Series A+ round, which will go toward development and commercialization of its non-invasive genetic tests for early-stage cancer detection and clinical validation studies.
The U.S. Food and Drug Administration signed off on San Diego-based Dexcom’s G6 diabetes monitoring system, which doesn’t require finger prick blood draws for calibration, it was announced March 27.
Luna DNA, a startup led by former Illumina executives, has filled out its leadership roster.
Ronald Giannotti has been appointed as COO of Toft Group Executive Search, a San Diego-based firm centered on executive searches in life sciences and health care.
A biomedical incubator has opened facilities for additive manufacturing and R&D in Carlsbad to aid medical device product development.